155 related articles for article (PubMed ID: 29408183)
21. Fatal invasive pulmonary aspergillosis in non-immunocompromised host: A case report.
Ao W; Huang P; Wang J; Fu X; Fu B
Medicine (Baltimore); 2023 Oct; 102(43):e35702. PubMed ID: 37904478
[TBL] [Abstract][Full Text] [Related]
22. Invasive aspergillosis in patients with cirrhosis, a case report and review of the last 10 years.
Jeurissen S; Vogelaers D; Sermijn E; Van Dycke K; Geerts A; Van Vlierberghe H; Colle I
Acta Clin Belg; 2013; 68(5):368-75. PubMed ID: 24579244
[TBL] [Abstract][Full Text] [Related]
23. Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report.
Witting C; Quaggin-Smith J; Mylvaganam R; Peigh G; Angarone M; Flaherty JD
Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115272. PubMed ID: 33388572
[TBL] [Abstract][Full Text] [Related]
24. Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a
Rößler S; Bader O; Stölzel F; Sommer U; Spiess B; Geibel S; Buchheidt D; Groß U; Baretton G; Jacobs E; Ostrosky-Zeichner L
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28743702
[TBL] [Abstract][Full Text] [Related]
25. Management of Aspergillus pleural empyema with combined systemic and intrapleural antifungal therapy in a pediatric patient: Case report.
Almuhareb A; Habib Z
J Infect Public Health; 2018; 11(2):280-282. PubMed ID: 28545901
[TBL] [Abstract][Full Text] [Related]
26. COVID-19-associated subacute invasive pulmonary aspergillosis.
Swain S; Ray A; Sarda R; Vyas S; Singh G; Jorwal P; Kodan P; Khanna P; Xess I; Sinha S; Wig N; Trikha A
Mycoses; 2022 Jan; 65(1):57-64. PubMed ID: 34541719
[TBL] [Abstract][Full Text] [Related]
27. Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
Paiva JA; Mergulhão P; Gomes A; Taccone FS; Van den Abeele AM; Bulpa P; Misset B; Meersseman W; Dimopoulos G; Rello J; Vogelaers D; Blot S
Int J Antimicrob Agents; 2017 Oct; 50(4):529-535. PubMed ID: 28669830
[TBL] [Abstract][Full Text] [Related]
28. Twenty-nine cases of invasive aspergillosis in neutropenic patients.
Saghrouni F; Ben Youssef Y; Gheith S; Bouabid Z; Ben Abdeljelil J; Khammari I; Fathallah A; Khlif A; Ben Saïd M
Med Mal Infect; 2011 Dec; 41(12):657-62. PubMed ID: 22036518
[TBL] [Abstract][Full Text] [Related]
29. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
Raad II; Zakhem AE; Helou GE; Jiang Y; Kontoyiannis DP; Hachem R
Int J Antimicrob Agents; 2015 Mar; 45(3):283-8. PubMed ID: 25455847
[TBL] [Abstract][Full Text] [Related]
30. Chronic necrotizing pulmonary aspergillosis.
Silva EF; Barbosa Mde P; Oliveira MA; Martins RR; Fontinele e Silva J
J Bras Pneumol; 2009 Jan; 35(1):95-8. PubMed ID: 19219337
[TBL] [Abstract][Full Text] [Related]
31. Voriconazole-refractory invasive aspergillosis.
Park SY; Yoon JA; Kim SH
Korean J Intern Med; 2017 Sep; 32(5):805-812. PubMed ID: 28835093
[TBL] [Abstract][Full Text] [Related]
32. IL-12 Influence mTOR to Modulate CD8
Wang H; Li J; Han Q; Yang F; Xiao Y; Xiao M; Xu Y; Su L; Cui N; Liu D
Int J Med Sci; 2017; 14(10):977-983. PubMed ID: 28924369
[No Abstract] [Full Text] [Related]
33. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
34. [Cardiac invasive aspergillosis in a heart transplant recipient].
Eworo A; Muñoz P; Yáñez JF; Palomo J; Guembe P; Roda J; Valerio M; Guinea J; Bouza E
Rev Iberoam Micol; 2011; 28(3):134-8. PubMed ID: 21700234
[TBL] [Abstract][Full Text] [Related]
35. Acute cholecystitis in a patient with metastatic renal cell carcinoma treated with everolimus.
Cetin B; Coskun U; Yildiz R; Buyukberber S; Baykara M; Benekli M
J Oncol Pharm Pract; 2011 Sep; 17(3):274-8. PubMed ID: 20215482
[TBL] [Abstract][Full Text] [Related]
36. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Tan BH; Low JG; Chlebicka NL; Kurup A; Cheah FK; Lin RT; Goh YT; Wong GC
Int J Infect Dis; 2011 May; 15(5):e350-6. PubMed ID: 21397541
[TBL] [Abstract][Full Text] [Related]
37. Invasive Pulmonary Aspergillosis with Hydropneumothorax in a Patient Taking High-Dose Glucocorticoids.
Dixit D; Kuete NT; Bene P; Khan I; Oprea-Ilies G; Flenaugh E
Am J Case Rep; 2020 Dec; 21():e928499. PubMed ID: 33361740
[TBL] [Abstract][Full Text] [Related]
38. Our 2015 approach to invasive pulmonary aspergillosis.
Liss B; Vehreschild JJ; Bangard C; Maintz D; Frank K; Grönke S; Michels G; Hamprecht A; Wisplinghoff H; Markiefka B; Hekmat K; Vehreschild MJ; Cornely OA
Mycoses; 2015 Jun; 58(6):375-82. PubMed ID: 25808916
[TBL] [Abstract][Full Text] [Related]
39. Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis.
Cornely OA; Meems L; Herbrecht R; Viscoli C; van Amsterdam RG; Ruhnke M
Mycoses; 2015 Jan; 58(1):58-64. PubMed ID: 25530265
[TBL] [Abstract][Full Text] [Related]
40. Comparison of CT features of Aspergillus and bacterial pneumonia in severely neutropenic patients.
Bruno C; Minniti S; Vassanelli A; Pozzi-Mucelli R
J Thorac Imaging; 2007 May; 22(2):160-5. PubMed ID: 17527120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
